Literature DB >> 18644018

The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality.

C Massone1, G Crisman, H Kerl, L Cerroni.   

Abstract

BACKGROUND: The influence of phenotype and detection of clonality on prognosis in early mycosis fungoides has never been addressed in large studies.
OBJECTIVES: To correlate immunophenotype and detection of clonality with clinical outcome.
METHODS: We analysed 73 biopsy specimens from 68 patients with early mycosis fungoides (stage Ia or Ib) and at least 10 years of follow up (or dead of disease).
RESULTS: Four phenotypic groups could be identified: group A (alpha/beta+ CD4+ CD8- TIA1-), 51 patients; median survival time 160 months; group B (alpha/beta+ CD4- CD8+ TIA1+), 10 patients; median survival time 195 months; group C (alpha/beta- CD4- CD8+/- TIA1+), five patients; median survival time 165 months; and group D (alpha/beta+ CD4- CD8- TIA1-), two patients; median survival time 130 months. Survival curves did not show statistical differences among the groups. Monoclonality was detected in 36 of 67 tested biopsies (54%), and statistical analyses did not show prognostic differences between the clonal and nonclonal cases.
CONCLUSIONS: We conclude that cytotoxic phenotype and detection of monoclonal T-cell receptor-gamma gene rearrangement in early lesions of mycosis fungoides do not have any prognostic significance.

Entities:  

Mesh:

Year:  2008        PMID: 18644018     DOI: 10.1111/j.1365-2133.2008.08761.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  16 in total

1.  Unusual variants of mycosis fungoides.

Authors:  Pooja Virmani; Patricia L Myskowski; Melissa Pulitzer
Journal:  Diagn Histopathol (Oxf)       Date:  2016-05-21

2.  Intraocular involvement of mycosis fungoides associated with immunophenotypic switch from CD4+ to CD8<sup/>.

Authors:  Jonathan A Braue; Anthony B Daniels; Jeffrey P Zwerner; Stephen J Kim; John A Zic
Journal:  Blood       Date:  2018-01-03       Impact factor: 22.113

Review 3.  [Mycosis fungoides or inflammatory dermatitis: differential diagnosis between early lymphoma and inflammation in skin biopsies].

Authors:  I Oschlies; W Klapper
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

Review 4.  The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.

Authors:  Rein Willemze; Lorenzo Cerroni; Werner Kempf; Emilio Berti; Fabio Facchetti; Steven H Swerdlow; Elaine S Jaffe
Journal:  Blood       Date:  2019-01-11       Impact factor: 22.113

5.  Two faces of gamma-delta mycosis fungoides: before and after renal transplantation.

Authors:  Knut Erich Prillinger; Franz Trautinger; Melitta Kitzwögerer; Johanna Eder
Journal:  BMJ Case Rep       Date:  2017-02-22

6.  CD8(+) mycosis fungoides with esophageal involvement: A case report.

Authors:  Mitsuaki Ishida; Yosuke Mochizuki; Yasuharu Saito; Yoshihide Fujiyama; Keiko Hodohara; Takashi Yoshida; Hidetoshi Okabe
Journal:  Oncol Lett       Date:  2012-10-16       Impact factor: 2.967

7.  CD30 expression and proliferative fraction in nontransformed mycosis fungoides.

Authors:  James T Edinger; Beth Z Clark; Brian E Pucevich; Larisa J Geskin; Steven H Swerdlow
Journal:  Am J Surg Pathol       Date:  2009-12       Impact factor: 6.394

8.  Poikiloderma vasculare atrophicans: a distinct clinical entity?

Authors:  Vikram K Mahajan; Pushpinder S Chauhan; Karaninder S Mehta; Anju Lath Sharma
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

9.  The influence of the coexpression of CD4 and CD8 in cutaneous lesions on prognosis of mycosis fungoides: a preliminary study.

Authors:  Sergio Umberto De Marchi; Giuseppe Stinco; Enzo Errichetti; Serena Bonin; Nicola di Meo; Giusto Trevisan
Journal:  J Skin Cancer       Date:  2014-07-20

10.  Clinicopathological analysis of 17 primary cutaneous T-cell lymphoma of the γδ phenotype from Japan.

Authors:  Yuka Takahashi; Katsuyoshi Takata; Seiichi Kato; Yasuharu Sato; Naoko Asano; Tetsuro Ogino; Kimio Hashimoto; Yukie Tashiro; Shogo Takeuchi; Taro Masunari; Yasushi Hiramatsu; Yoshinobu Maeda; Mitsune Tanimoto; Tadashi Yoshino
Journal:  Cancer Sci       Date:  2014-06-18       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.